Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Rat Cell Lines
AT3B-1
AT3B-1 from ATCC
Be the first to write a review!
Citations:
(3)
Supplier Page
Supplier Page from
ATCC for
AT3B-1
Request Info
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
AT3B-1
Company
ATCC
Price
$0.00
Supplier Page
View Company Product Page
Catalog Number
CRL-2375
Species
Rattus norvegicus
Type
Cell Biology
Validated Species Reactivity
Rat (Rt)
Age
22 months
Disease
Carcinoma
Tissue
Prostate
Applications
AT3B-1 was derived from the AT-3 cell line.They are more resistant to vinblastine compared to controls.These cells express a multidrug (MDR) resistant phenotype.Injection of AT3 B-1 cells into rats followed by doxorubicin treatment produced larger tumors compared to the parental controls.When P-glycoprotein was blocked, the AT3 B-1 cell line demonstrated drug efflux pump activity.This cell line can be used to study chemotherapy resistance in prostate cancer
Specifications/Features
Post freeze viability ≥ 50%
Add to Compare List
ATCC
10801 University Boulevard
Manassas
,
Virginia
20110-2209
United States
Phone
: (703) 365-2700
Fax: (703) 365-2701
Company Profile
Website:
http://www.atcc.org
Citations (3)
(1)
Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein
Pharmaceuticals (Basel, Switzerland)
December 10, 2021
Pulukuri AJ, Burt AJ, Opp LK, McDowell CM, Davaritouchaee M, Nielsen AE, Mancini RJ.
[53]. The
AT3B-1
cell line was purchased from ATCC. The
AT3B-1
cell line (
ATCC
, Manassas, VA, USA,
CRL-2375
,
rat
MDR
prostate
carcinoma
) was grown in complete culture media composed of
DMEM
with 4.5 g L−1 glucose,
(2)
Immune responses against PSMA after gene-based vaccination for immunotherapy – A: results from immunizations in animals
Cancer Gene Therapy
April 1, 2006
M Mincheff, S Zoubak, Y Makogonenko
vector containing zeocin resistance gene.
AT3B-1
transfection
with hPSMAs Monolayers of
AT3B-1
cells (
CRL-2375
;
ATCC
, Manassas, VA) were
transfected
with the hPSMAs using the FuGENE6
transfection reagent
(Roche
(3)
Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein
Cancer gene therapy
February 1, 2005
Mincheff M, Zoubak S, Altankova I, Tchakarov S, Pogribnyy P, Makogonenko Y, Botev C, Meryman HT.
Woodlands, TX). The
human
LNCaP (
CRL-1740
), T2 (
CRL-1992
),
Malme 3
M (
HTB-64
),
COS-1
(
CRL-1650
) and
AT3B-1
(
CRL2375
) cell lines were purchased from
ATCC
and were maintained according to ATCC instructions. Cytokines
<<
<
>
>>
Reviews
Be the First to Write a Review!
AT3B-1 from ATCC
Supplier Page
View Company Product Page
$0.00
Product Specs
Company Info
Citations
Reviews
Back To Top